1. Home
  2. NSPR vs FMY Comparison

NSPR vs FMY Comparison

Compare NSPR & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • FMY
  • Stock Information
  • Founded
  • NSPR 2005
  • FMY 2005
  • Country
  • NSPR Israel
  • FMY United States
  • Employees
  • NSPR N/A
  • FMY N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • FMY Finance/Investors Services
  • Sector
  • NSPR Health Care
  • FMY Finance
  • Exchange
  • NSPR Nasdaq
  • FMY Nasdaq
  • Market Cap
  • NSPR 63.0M
  • FMY 52.1M
  • IPO Year
  • NSPR N/A
  • FMY N/A
  • Fundamental
  • Price
  • NSPR $2.45
  • FMY $12.02
  • Analyst Decision
  • NSPR Buy
  • FMY
  • Analyst Count
  • NSPR 1
  • FMY 0
  • Target Price
  • NSPR $4.50
  • FMY N/A
  • AVG Volume (30 Days)
  • NSPR 36.4K
  • FMY 10.1K
  • Earning Date
  • NSPR 11-12-2024
  • FMY 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • FMY 6.98%
  • EPS Growth
  • NSPR N/A
  • FMY N/A
  • EPS
  • NSPR N/A
  • FMY N/A
  • Revenue
  • NSPR $6,821,000.00
  • FMY N/A
  • Revenue This Year
  • NSPR $12.28
  • FMY N/A
  • Revenue Next Year
  • NSPR $53.44
  • FMY N/A
  • P/E Ratio
  • NSPR N/A
  • FMY N/A
  • Revenue Growth
  • NSPR 24.70
  • FMY N/A
  • 52 Week Low
  • NSPR $1.81
  • FMY $10.71
  • 52 Week High
  • NSPR $3.42
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 61.14
  • FMY 41.91
  • Support Level
  • NSPR $2.07
  • FMY $11.93
  • Resistance Level
  • NSPR $3.05
  • FMY $12.08
  • Average True Range (ATR)
  • NSPR 0.22
  • FMY 0.12
  • MACD
  • NSPR 0.03
  • FMY 0.01
  • Stochastic Oscillator
  • NSPR 63.92
  • FMY 30.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities.

Share on Social Networks: